Nyheder
SOM Biotech afslutter rekrutteringsprocessen i fase IIb-studiet af behandling af chorea ved Huntingtons sygdom
SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligence platform (SOMAIPRO®), is pleased to announce that the recruitment of the Phase IIb clinical study with SOM3355 as a Læs mere...
0 Kommentarer